|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Reconciliation of net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred financing cost amortization | |||||
| Stock-based compensation | |||||
| Provision for expected credit losses | |||||
| Inventory obsolescence | |||||
| Gain on disposal of assets | |||||
| Deferred income taxes | |||||
| Change in fair value of earn-out liability | |||||
| (Gain) loss from revaluation of liability related to tax receivable agreement | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Payments pursuant to tax receivable agreement | |||||
| Payment of earn-out liability | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of a business, net of cash and cash equivalents acquired | |||||
| Investment in unconsolidated affiliates | |||||
| Capital expenditures and other | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of long-term debt | |||||
| Repayments of borrowings of long-term debt | |||||
| Payment of contingent consideration | |||||
| Net proceeds from the issuance of Class A common stock | |||||
| Payments of deferred financing costs | |||||
| Payments on finance leases | |||||
| Dividends paid to Class A common stock shareholders | |||||
| Distributions to members | |||||
| Repurchases of shares | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash | |||||
| Beginning of period | |||||
| End of period |
Loading...